Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 11/20 | 1.00 |
| ▸ | CYP11B1 | P15538 | 3/20 | 0.59 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.59 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.59 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.59 |
| ▸ | MAOA | P21397 | 2/20 | 0.55 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.55 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.53 |
| ▸ | CA12 | O43570 | 2/20 | 0.50 |
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | CA9 | Q16790 | 2/20 | 0.50 |
| ▸ | HTR1A | P08908 | 1/20 | 0.48 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.47 |
| ▸ | MIF | P14174 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3456742 | 0.89 | MAOB (0.79) | MAOBCYP11B1CYP11B2CYP17A1CYP19A1 | |
| SCHEMBL20378369 | 0.86 | MAOB (0.76) | MAOBCYP11B1CYP11B2CYP17A1CYP19A1 | |
| SCHEMBL12655257 | 0.85 | MAOB (0.73) | MAOBCYP11B1CYP11B2CYP17A1CYP19A1 | |
| SCHEMBL6511946 | 0.84 | MAOB (0.71) | MAOBCYP11B1CYP11B2CYP17A1CYP19A1 | |
| SCHEMBL9075843 | 0.83 | MAOB (0.71) | MAOBCYP11B1CYP11B2CYP17A1CYP19A1 | |
| SCHEMBL292868 | 0.83 | MAOB (0.71) | MAOBCYP11B1CYP11B2CYP17A1CYP19A1 | |
| SCHEMBL8359747 | 0.83 | MAOB (0.71) | MAOBCYP11B1CYP11B2CYP17A1CYP19A1 | |
| SCHEMBL1305435 | 0.81 | MAOB (0.68) | MAOBCYP11B1CYP11B2CYP17A1CYP19A1 | |
| SCHEMBL11869359 | 0.81 | MAOB (0.68) | MAOBCYP11B1CYP11B2CYP17A1CYP19A1 | |
| SCHEMBL536553 | 0.80 | MAOB (0.67) | MAOBCYP11B1CYP11B2CYP17A1CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115636808-B | Chromone-benzoyl hydrazone alpha-glucosidase inhibitor and preparation method and application thereof | 贵州医科大学附属医院 | 2023-10-17 | — | — | CN | claimed |
| CN-115636808-A | Chromone-benzoyl hydrazone alpha-glucosidase inhibitor as well as preparation method and application thereof | 贵州医科大学附属医院 | 2023-01-24 | — | — | CN | claimed |
| EP-1115717-B1 | 3-(HYDROXYMETHYL)CHROMEN-4-ONES AND PROCESS FOR THEIR PREPARATION | FERRER INT (ES) | 2004-03-10 | — | — | EP | claimed |
| US-6348605-B1 | TREATING 2-(HYDROXY)CHROMAN-4-ONES WITH FORMALDEHYDE AND BASIC CATALYST FOLLOWED BY DEHYDRATION IN ACID MEDIUM | FERRER INTERNACIONAL, S.A. (ES) | 2002-02-19 | — | — | US | claimed |
| EP-1115717-A1 | 3-(HYDROXYMETHYL)CHROMEN-4-ONES AND PROCESS FOR THEIR PREPARATION | FERRER INTERNACIONAL, S.A. (ES) | 2001-07-18 | — | — | EP | claimed |
| WO-2000017183-A1 | 3-(HYDROXYMETHYL)CHROMEN-4-ONES AND PROCESS FOR PREPARING | FERRER INTERNACIONAL, S.A. (ES) | 2000-03-30 | — | — | WO | claimed |
| US-12162863-B2 | Modulators of stimulator of interferon genes (STING) | Ryvu Therapeutics S.A. (PL) | 2024-12-10 | — | — | US | disclosed |
| CN-115636808-B | Chromone-benzoyl hydrazone alpha-glucosidase inhibitor and preparation method and application thereof | 贵州医科大学附属医院 | 2023-10-17 | — | — | CN | disclosed |
| CN-115636808-A | Chromone-benzoyl hydrazone alpha-glucosidase inhibitor as well as preparation method and application thereof | 贵州医科大学附属医院 | 2023-01-24 | — | — | CN | disclosed |
| US-20220402898-A1 | MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) | Ryvu Therapeutics S.A. (PL) | 2022-12-22 | — | — | US | disclosed |
| US-20220402898-A1 | MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) | Ryvu Therapeutics S.A. (PL) | 2022-12-22 | — | — | US | disclosed |
| EP-3807264-A1 | MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) | Ryvu Therapeutics S.A. (PL) | 2021-04-21 | — | — | EP | disclosed |
| WO-2019238786-A1 | MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) | Ryvu Therapeutics S.A. (PL) | 2019-12-19 | — | — | WO | disclosed |
| WO-1997028157-A1 | NOVEL PIPERIDINE DERIVATIVES 4-SUBSTITUTED BY AN IMIDAZOLIDIN-2-ON-1-YL-ETHYL, TETRAHYDROPYRIMIDIN-2-ON-1-YL-ETHYL AND 1,3-DIAZEPIN-2-ON-1-YL-ETHYL GROUP, AND USE THEREOF AS α2-ADRENERGIC RECEPTOR ANTAGONISTS | PIERRE FABRE MEDICAMENT (FR) | 1997-08-07 | — | — | WO | disclosed |
| US-4327091-A | ANTIINFLAMMATORY AGENTS | CIBA-GEIGY CORPORATION (US) | 1982-04-27 | — | — | US | disclosed |
| US-4213980-A | ANTIINFLAMMATORY AGENTS | CIBA-GEIGY CORPORATION (US) | 1980-07-22 | — | — | US | disclosed |
| US-4098799-A | ANTIALLERGENS, HYPERACIDITY | WARNER-LAMBERT COMPANY (US) | 1978-07-04 | — | — | US | disclosed |
| US-4008252-A | ANTIALLERGENS, ANTIHYPERACIDITY | WARNER-LAMBERT COMPANY (US) | 1977-02-15 | — | — | US | disclosed |
| US-3937837-A | SUBSTITUTED CHROMONE-3-CARBONITRILES, CARBOXAMIDES AND CARBOXYLIC ACIDS USEFUL FOR PREVENTING ASTHMATIC SYMPTOMS | WARNER-LAMBERT COMPANY (US) | 1976-02-10 | — | — | US | disclosed |
| US-3887584-A | 3-(Hydroxymethyl)chromones | WARNER LAMBERT CO | 1975-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12162863-B2 | Modulators of stimulator of interferon genes (STING) | STING1, IRF3, CGAS | MAOB 730/4885CYP11B1 43/4885CYP11B2 50/4885 |
| US-20220402898-A1 | MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) | STING1, IRF3, CGAS | MAOB 730/4885CYP11B1 43/4885CYP11B2 50/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.